Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

WGS

+ Watchlist+ Portfolio

GeneDx Holdings Corp.

Regulated industrySells to businessesTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$51.96
52-Week Range
$32.21 – $170.87
Market Cap
$1.48B
P/E (TTM)
—
EPS (TTM)
-3.76
Dividend Yield
0.00%
Advanced Metrics
Price/Book
6.03
PEG Ratio
—
Return on Equity
-41.36%
Return on Assets
-7.72%
Gross Margin
68.76%
Operating Margin
-13.68%
Profit Margin
-24.10%
Current Ratio
4.16
Debt/Equity
0.88
Total Debt
$215.38M
Free Cash Flow
$-70.29M
Revenue Growth
5.40%
Earnings Growth
—
Enterprise Value
$1.60B

Market Snapshot

About

GeneDx Holdings Corp. is a leading genomic testing and diagnostic company that provides comprehensive genetic testing services. The company specializes in whole exome and whole genome sequencing, offering solutions for rare disease diagnosis, cancer genomics, and reproductive health.